Drilldown: Medicines
More actions
Use the filters below to narrow your results.
Monoamine releasing agent (1) ·
Potent 5-HT2A agonist (1) ·
'"`UNIQ--vote-0000113A-QINU`"' Concomitant β-blocker or CCB is required when used for AF to prevent 1:1 atrial flutter conduction (flecainide can slow atrial rate to a level where AV conduction allows dangerous ventricular rates). CYP2D6 substrate'"`UNIQ--ref-0000113B-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.


